Close Menu

The Mayo Clinic is starting a pilot study to sequence patients in an effort to personalize their health care, reports Ian Sample at the Guardian. Patients will either have their entire genome, disease-related genes, or drug metabolism-related genes sequenced. "The project will help managers at the clinic decide whether it makes sense to read and store a patient's whole genome early on, instead of ordering single genetic tests as and when the need arises," Sample says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.